(Q22010687)

Fibroblast growth factor 19

GOA release 2020-03-11

1 reference

fibroblast growth factor binding

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

M H Xie

1

M H

Xie

1 reference

7 February 2023

I Holcomb

2

I

Holcomb

1 reference

7 February 2023

B Deuel

3

B

Deuel

1 reference

7 February 2023

P Dowd

4

P

Dowd

1 reference

7 February 2023

A Huang

5

A

Huang

1 reference

7 February 2023

A Vagts

6

A

Vagts

1 reference

7 February 2023

J Foster

7

J

Foster

1 reference

7 February 2023

J Liang

8

J

Liang

1 reference

7 February 2023

J Brush

9

J

Brush

1 reference

7 February 2023

Q Gu

10

Q

Gu

1 reference

7 February 2023

K Hillan

11

K

Hillan

1 reference

7 February 2023

A Goddard

12

A

Goddard

1 reference

7 February 2023

A L Gurney

13

A L

Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview.

Gurney

1 reference

7 February 2023

language of work or name

English

0 references

publication date

October 1999

0 references

published in

Cytokine

0 references

volume

11

0 references

page(s)

729-35

0 references

issue

10

0 references

cites work

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Expression of FGF and FGF receptor genes in human breast cancer

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Fibroblast growth factors: at the heart of angiogenesis

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene.

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

FGFR activation in skeletal disorders: too much of a good thing

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Functions of fibroblast growth factors in vertebrate development

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Nature of the interaction of heparin with acidic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Receptor binding and mitogenic properties of mouse fibroblast growth factor 3. Modulation of response by heparin

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Receptor specificity of the fibroblast growth factor family

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Association of a 85-kDa serine kinase with activated fibroblast growth factor receptor-4

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Expression and biological activity of mouse fibroblast growth factor-9

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Craniosynostosis: genes and mechanisms

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

The molecular biology of heparan sulfate fibroblast growth factor receptors

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Fibroblast growth factor receptors have different signaling and mitogenic potentials

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021

FGF signaling in skeletal development.

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.1999.0485

7 January 2021